Neurobiology of glaucomatous optic neuropathy - Diverse cellular events in neurodegeneration and neuroprotection

被引:87
作者
Wax, MB
Tezel, G
机构
[1] Pharmacia Corp, St Louis, MO 63138 USA
[2] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[3] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA
关键词
apoptosis; glaucoma; neurodegeneration; neuroprotection; retinal ganglion cells;
D O I
10.1385/MN:26:1:045
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although glaucomatous optic nerve degeneration is a leading cause of worldwide blindness, neither the precise cellular mechanisms underlying neurodegeneration in glaucoma, nor effective strategies for neuroprotection are yet clear. This review focuses on diverse cellular events associated with glaucomatous neurodegeneration whose balance is critical for determination of ultimate cell fate. An improved understanding of the site of primary injury to optic nerve, the mediator pathways of apoptotic cell death and intrinsic protection mechanisms in retinal ganglion cells, the role of glial activation on the survival and death of retinal ganglion cell bodies and their axons, and the protective and destructive consequences of immune system involvement can facilitate development of effective neuroprotective strategies in glaucoma.
引用
收藏
页码:45 / 55
页数:11
相关论文
共 107 条
[51]   Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma [J].
Neufeld, AH ;
Sawada, A ;
Becker, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) :9944-9948
[52]   Nitric oxide synthase in the human glaucomatous optic nerve head [J].
Neufeld, AH ;
Hernandez, MR ;
Gonzalez, M .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (04) :497-503
[53]   Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death [J].
Nickells, RW .
SURVEY OF OPHTHALMOLOGY, 1999, 43 :S151-S161
[54]  
Park KH, 2001, INVEST OPHTH VIS SCI, V42, P1522
[55]  
Park YM, 1998, J CELL PHYSIOL, V174, P27, DOI 10.1002/(SICI)1097-4652(199801)174:1<27::AID-JCP4>3.0.CO
[56]  
2-I
[57]  
Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764
[58]  
Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.3.CO
[59]  
2-E
[60]  
QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137